TruAlt Bioenergy Ltd (NSE: TRUALT, BSE: 544545) is a Bengaluru, Karnataka-based company in the Ethanol & Biofuels industry. With a market capitalisation of ₹2,973 Cr, it ranks #1,064 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 3 in Ethanol & Biofuels. At ₹350.10 (as of 16 Nov 2026), the share price is 35.4% below its 52-week high of ₹542.00 and 12.9% above its 52-week low of ₹310.20. The share price is down 16.6% over one year and down 27.9% over three months.
| Current Price | ₹350.10 |
|---|---|
| Market Cap | ₹2,973 Cr |
| NSE Symbol | TRUALT |
| BSE Code | 544545 |
| Sector | Energy > Energy > Oil, Gas and Consumable Fuels |
| Sub-Industry | Renewable Fuels > Ethanol & Biofuels |
| P/E Ratio | 27.9 |
| Return on Equity | 8.25% |
| Return on Assets | 3.74% |
| 52-Week Range | ₹310.20 – ₹542.00 |
| 1-Year Price Change | -16.6% |
| 3-Month Price Change | -27.9% |
| Beta (1Y) | 0.33 |
| Headquarters | Bengaluru, Karnataka |
| Website | www.trualtbioenergy.com |
| Revenue | ₹811 Cr |
|---|---|
| Net Profit | ₹35 Cr |
| Net Margin | 4.3% |
| EPS (Basic) | ₹4.04 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
TruAlt Bioenergy Ltd reported revenue of ₹811 Cr in Q2 FY27, up 606.2% from ₹115 Cr in Q2 FY26 and up 29.4% from ₹627 Cr in Q1 FY27. It posted a net profit of ₹35 Cr for the quarter, against a net loss of ₹38 Cr in Q2 FY26. Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹115 Cr (Q2 FY26) to ₹811 Cr (Q2 FY27). The company reported a net loss in 1 of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹811 Cr | ₹35 Cr | 4.3% |
| Q1 FY27 | ₹627 Cr | ₹59 Cr | 9.5% |
| Q4 FY26 | ₹596 Cr | ₹61 Cr | 10.2% |
| Q3 FY26 | ₹713 Cr | ₹69 Cr | 9.7% |
| Q2 FY26 | ₹115 Cr | −₹38 Cr | −33.0% |
| Q1 FY26 | ₹304 Cr | ₹5 Cr | 1.6% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 71.38% of TruAlt Bioenergy Ltd's shares as of Sept 2026, against 70.55% in Oct 2025 (+0.83 percentage points). Delivery averaged 56.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
TruAlt Bioenergy Limited produces and sells biofuels in India. Its products include ethanol, compressed biogas, extra neutral alcohol, and fermented organic manure. The company was formerly known as TruAlt Energy Limited and changed its name to TruAlt Bioenergy Limited in July 2022. TruAlt Bioenergy Limited was incorporated in 2021 and is based in Bengaluru, India.
1. Producing Ethanol-This segment engages in the production and processing of bio-diesel, ethanol, and compressed bio gas. 2. NA-NA 3. NA-NA 4. NA-NA
1. Ethanol and Other Products-98.7% 2. Compressed Biogas-1.3%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| TruAlt Bioenergy Ltd | ₹2,973 Cr | 27.9 | 8.25% | ₹811 Cr | -16.6% |
| Godavari Biorefineries Limited | ₹1,159 Cr | 329.5 | 0.45% | ₹549 Cr | -13.5% |
| Tulasee Bio-Ethanol Ltd. | ₹0 Cr | n/m | — | — | -55.1% |
Listed by market capitalisation. Ratios are shown for context only.
TruAlt Bioenergy Ltd is trading at ₹350.10, with a market capitalisation of ₹2,973 Cr.
TruAlt Bioenergy Ltd operates in the Energy > Energy > Oil, Gas and Consumable Fuels space (Renewable Fuels > Ethanol & Biofuels).
TruAlt Bioenergy Ltd has a P/E of 27.9 and a return on equity of 8.25%.
TruAlt Bioenergy Ltd is listed on the NSE under the symbol TRUALT and on the BSE under the scrip code 544545.
TruAlt Bioenergy Ltd's share price is down 16.6% over one year and down 27.9% over three months. Its 52-week range is ₹310.20 to ₹542.00.
In Q2 FY27, TruAlt Bioenergy Ltd reported revenue of ₹811 Cr and net profit of ₹35 Cr, with basic EPS of ₹4.04 (consolidated, parsed from the company's exchange filing).
TruAlt Bioenergy Ltd reported revenue of ₹811 Cr in Q2 FY27, up 606.2% from ₹115 Cr in Q2 FY26 and up 29.4% from ₹627 Cr in Q1 FY27.
Promoters held 71.38% of TruAlt Bioenergy Ltd's shares as of Sept 2026, against 70.55% in Oct 2025 (+0.83 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.